Healthcare CRO Market, By Type (Drug Discovery, Clinical, and Preclinical), By Service (Project Management/Clinical Supply Management, Data Management, Clinical Monitoring, Regulatory/Medical Affairs, Quality Management/Assurance, Medical Writing, Bio-statistics, Investigator Payments, Technology, Laboratory, Patient, and Site Recruitment), and By Geography (NA, APAC, EU, LATAM, and MEA) Analysis, Trends, & Forecast from 2020-2026
REPORT HIGHLIGHT
Healthcare CRO market was valued at USD 36.8 billion by 2019, growing with 6.5% CAGR during the forecast period, 2020-2026
Contract Research Organization or CRO is an organization contracted by other companies to lead and manage the company’s functions, duties, and trials. Businesses or organizations contract with CROs in order to acquire specific expertise without any need to hire permanent staff. The CRO provides support to the biotechnology, pharmaceutical, and medical device industries for specific services based on a contract. The services may be drug development, clinical research, or process development. A CRO also provides management services such as pharmacovigilance and clinical trials management.
Market Dynamics
Advancements in the field of technology, drug development, and disease study are some of the major factors driving the growth of global healthcare CRO market. CROs help in saving extra cost and also help manufacturers in saving time taken to conduct a trial in a private lab. Additionally, a determined need has been witnessed for developments in stem cell research, oncology, drug discovery, cancer research, and to study diverse small molecules and their mechanisms. Small as well as medium-sized biotechnology and pharmaceutical companies are continually focusing to conduct clinical trials for their products. Many of the CROs use trial master file (TMF) which may be submitted in paper form or a simple file transfer. However, this limits the access to the trials and hence a new system named eTMF is being adopted. Through this technology, the sponsor can improve the collaboration apart from greater trial efficiency and accessibility.
Type Takeaway
On the basis of type, the global industry is categorized into drug discovery, target validation, lead identification, lead optimization, clinical, and pre-clinical healthcare CRO. Of these types, the clinical segment valued at the largest market share in 2018 and is anticipated to exhibit a momentous growth rate during the forecast period. This significant growth is owing to the growing demand for clinical trials to develop innovative medical devices and novel drugs. Clinical type is further segmented into Phase I, II, III, IV trial services. For instance, in October 2015, Quintiles and IMS Health together formed an alliance to access Phase-IV data authorization for further clinical research. This collaboration aimed to provide a pioneering advantage for CROs execution of phase IV studies.
Service Takeaway
Based on service, the global industry is categorized into data management, project management/clinical supply management, regulatory/medical affairs, clinical monitoring, medical writing, quality management/ assurance, investigator payments, bio-statistics, laboratory, technology, site recruitment, patient, and others. Of these services, the clinical monitoring services accounted for the largest market share in 2019 and the segment for regulatory/medical affairs services is anticipated to grow at a steady pace during the period of forecast.
With the increase in privatization of clinical trials, the drug companies are now outsourcing production of medicines as well as clinical trials. Over the past decade, clinical research is being outsourced to CROs owing to several reasons such as technical expertise and cost-effectiveness. The introduction of real-time devices for data acquisition and smart analytics in the healthcare sector is projected to enhance clinical monitoring data. Real-time data acquisition associated with toxicity and drug safety allows early identification of trial errors. The real-time acquisition also enables timely rectifications such as termination or trial re-design, which is ultimately propelling the segment growth.
Regional Takeaway
Geographically, the global market for blood donor screening is classified into North America, Asia Pacific, Europe, LATAM, and MEA. The North America healthcare CRO market accounted for a significant share in 2019 and is estimated to grow exponentially by the end of 2026. This growth is majorly due to a large number of trials are outsourced and undertaken in this region. Besides, the rising support of the government for R&D activities through funds and grants to companies & research institutes has uplifted this regional market. For example, the U.S. government in January 2015 had announced $215.0 million investment for the initiative of precision medicine. The investment was for the FDA, NCI (National Cancer Institute), and NIH.
The Asia Pacific market for healthcare CRO is expected to grow rapidly in the projected timeframe owing to the growing interest of healthcare companies of developed countries to expand their presence and explore new opportunities. This region was valued for the largest market share in 2019 and is expected to grow at a speedy pace by 2026. In the Asia Pacific region, there is a growing prevalence of chronic conditions and easy patient retention and recruitment, which are other factors responsible for the growth of healthcare CRO market in this region. For instance, in February 2018, the CDSCO of India drafted new rules and regulations that are projected to reduce the required time for approval of novel drugs within 30 to 60 days, which will also propel the market growth.
Key Vendor Takeaway
Some of the prominent players of the global industry include Covance, Quintiles, Pharmaceutical Product Development, LLC (PPD), Charles River Laboratories (CRL), Parexel, Medidata Solutions, and ICON, Plc. These players are adopting several strategies such as product development, mergers & acquisitions, partnerships, collaborations, and R&D activities to strengthen their position in the global industry.
For instance, Quintiles held the significant market share in 2019 due to the increasing strategic initiatives being adopted by the company. In August 2013, Quintiles acquired Novella for USD 146.5 million to mark its presence in the oncology segment. The collaborative efforts will enable both companies to expand in the emerging market of oncology and its medical devices. Moreover, in March 2015, Novella expanded its workforce by adding 90 workers after its acquisition by Quintiles in 2013. Quintiles has strategic alliances with companies such as Ascendancy Healthcare, Merck Serono, BMS, Samsung, and Eisai.
The market size and forecast for each segment and sub-segments has been considered as below:
- Historical Year – 2015 to 2018
- Base Year – 2019
- Estimated Year – 2020
- Projected Year – 2026
TARGET AUDIENCE
- Traders, Distributors, and Suppliers
- Manufacturers
- Government and Regional Agencies
- Research Organizations
- Consultants
- Distributors
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
KEY PLAYERS
- Covance
- Syneos Health
- Quintiles
- Pharmaron
- Pharmaceutical Product Development, LLC (PPD)
- IQVIA
- Charles River Laboratories (CRL)
- Parexel
- GVK Biosciences Private Limited
- Medidata Solutions
- ICON, Plc.
MARKET, BY TYPE
- Drug Discovery
- Lead Identification
- Target Validation
- Lead Optimization
- Clinical
- Phase I Trial Services
- Phase II Trial Services
- Phase III Trial Services
- Phase IV Trial Services
- Pre-Clinical
MARKET, BY SERVICE
- Data Management
- Project Management/Clinical Supply Management
- Regulatory/Medical Affairs
- Clinical Monitoring
- Medical Writing
- Quality Management/Assurance
- Investigator Payments
- Bio-statistics
- Laboratory
- Technology
- Site Recruitment
- Patient
- Others
MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Singapore
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Rest of MEA
TABLE OF CONTENT
1. HEALTHCARE CRO MARKET OVERVIEW
1.1. Study Scope
1.2. Assumption and Methodology
2. EXECUTIVE SUMMARY
2.1. Market Snippet
2.1.1. Market Snippet by Type
2.1.2. Market Snippet by Services
2.1.3. Market Snippet by Region
2.2. Competitive Insights
3. HEALTHCARE CRO KEY MARKET TRENDS
3.1. Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Market Opportunities
3.4. Market Future Trends
4. HEALTHCARE CRO INDUSTRY STUDY
4.1. Porter’s Five Forces Analysis
4.2. Marketing Strategy Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. HEALTHCARE CRO MARKET LANDSCAPE
5.1. Market Share Analysis
5.2. Key Innovators
5.3. Breakdown Data, by Key manufacturer
5.3.1. Established Player Analysis
5.3.2. Emerging Player Analysis
6. HEALTHCARE CRO MARKET – BY TYPE
6.1. Overview
6.1.1. Segment Share Analysis, By Type, 2019 & 2026 (%)
6.2. Drug Discovery
6.2.1. Overview
6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
6.2.3. Target Validation
6.2.3.1. 6.2.3.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
6.2.4. Lead Identification
6.2.4.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
6.2.5. Lead Optimization
6.2.5.1. 6.2.5.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
6.3. Clinical
6.3.1. Overview
6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
6.3.3. Phase I Trial Services
6.3.3.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
6.3.4. Phase II Trial Services
6.3.4.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
6.3.5. Phase III Trial Services
6.3.5.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
6.3.6. Phase IV Trial Services
6.3.6.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
6.4. Pre-Clinical
6.4.1. Overview
6.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
7. HEALTHCARE CRO MARKET – BY SERVICE
7.1. Overview
7.1.1. Segment Share Analysis, By Service, 2019 & 2026 (%)
7.2. Data Management
7.2.1. Overview
7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
7.3. Project Management/Clinical Management
7.3.1. Overview
7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
7.4. Regulatory/Medical Affairs
7.4.1. Overview
7.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
7.5. Clinical Monitoring
7.5.1. Overview
7.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
7.6. Medical Writing
7.6.1. Overview
7.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
7.7. Quality Management/Assurance
7.7.1. Overview
7.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
7.8. Investigator Payments
7.8.1. Overview
7.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
7.9. Biostatistics
7.9.1. Overview
7.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
7.10. Laboratory
7.10.1. Overview
7.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
7.11. Technology
7.11.1. Overview
7.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
7.12. Site Recruitment
7.12.1. Overview
7.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
7.13. Patient
7.13.1. Overview
7.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
7.14. Others
7.14.1. Overview
7.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8. HEALTHCARE CRO MARKET– BY GEOGRAPHY
8.1. Introduction
8.1.1. Segment Share Analysis, By Region, 2019 & 2026 (%)
8.2. North America
8.2.1. Overview
8.2.2. Key Manufacturers in North America
8.2.3. North America Market Size and Forecast, By Country, 2015 – 2026 (US$ Million)
8.2.4. North America Market Size and Forecast, By Type, 2015 – 2026 (US$ Million)
8.2.5. North America Market Size and Forecast, By Service, 2015 – 2026 (US$ Million)
8.2.6. U.S.
8.2.6.1. Overview
8.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.2.7. Canada
8.2.7.1. Overview
8.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.3. Europe
8.3.1. Overview
8.3.2. Key Manufacturers in Europe
8.3.3. Europe Market Size and Forecast, By Country, 2015 – 2026 (US$ Million)
8.3.4. Europe Market Size and Forecast, By Type, 2015 – 2026 (US$ Million)
8.3.5. Europe Market Size and Forecast, By Service, 2015 – 2026 (US$ Million)
8.3.6. Germany
8.3.6.1. Overview
8.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.3.7. Italy
8.3.7.1. Overview
8.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.3.8. United Kingdom
8.3.8.1. Overview
8.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.3.9. France
8.3.9.1. Overview
8.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.3.10. Rest of Europe
8.3.10.1. Overview
8.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.4. Asia Pacific (APAC)
8.4.1. Overview
8.4.2. Key Manufacturers in Asia Pacific
8.4.3. Asia Pacific Market Size and Forecast, By Country, 2015 – 2026 (US$ Million)
8.4.4. Asia Pacific Market Size and Forecast, By Type, 2015 – 2026 (US$ Million)
8.4.5. Asia Pacific Market Size and Forecast, By Service, 2015 – 2026 (US$ Million)
8.4.6. India
8.4.6.1. Overview
8.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.4.7. China
8.4.7.1. Overview
8.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.4.8. Japan
8.4.8.1. Overview
8.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.4.9. South Korea
8.4.9.1. Overview
8.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.4.10. Rest of APAC
8.4.10.1. Overview
8.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.5. Latin America
8.5.1. Overview
8.5.2. Key Manufacturers in Latin America
8.5.3. Latin America Market Size and Forecast, By Country, 2015 – 2026 (US$ Million)
8.5.4. Latin America Market Size and Forecast, By Type, 2015 – 2026 (US$ Million)
8.5.5. Asia Pacific Market Size and Forecast, By Service, 2015 – 2026 (US$ Million)
8.5.6. Brazil
8.5.6.1. Overview
8.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.5.7. Mexico
8.5.7.1. Overview
8.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.5.8. Argentina
8.5.8.1. Overview
8.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.5.9. Rest of LATAM
8.5.9.1. Overview
8.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.6. Middle East and Africa
8.6.1. Overview
8.6.2. Key Manufacturers in Middle East and Africa
8.6.3. Middle East and Africa Market Size and Forecast, By Country, 2015 – 2026 (US$ Million)
8.6.4. Middle East and Africa Market Size and Forecast, By Type, 2015 – 2026 (US$ Million)
8.6.5. Middle East and Africa Market Size and Forecast, By Service, 2015 – 2026 (US$ Million)
8.6.6. Saudi Arabia
8.6.6.1. Overview
8.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.6.7. United Arab Emirates
8.6.7.1. Overview
8.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
9. KEY VENDOR ANALYSIS
9.1. Covance
9.1.1. Company Snapshot
9.1.2. Financial Performance
9.1.3. Product Benchmarking
9.1.4. Strategic Initiatives
9.2. Syneos Health
9.3. Quintiles
9.4. Pharmaron
9.5. Pharmaceutical Product Development, LLC (PPD)
9.6. IQVIA
9.7. Charles River Laboratories (CRL)
9.8. Parexel
9.9. GVK Biosciences Private Limited
9.10. Medidata Solutions
9.11. ICON, Plc.
10. 360 DEGREE ANALYSTVIEW
11. APPENDIX
11.1. Research Methodology
11.2. References
11.3. Abbreviations
11.4. Disclaimer
11.5. Contact Us
List of Tables
TABLE List of data sources
TABLE Market drivers; Impact Analysis
TABLE Market restraints; Impact Analysis
TABLE Healthcare CRO market: Type Snapshot (2018)
TABLE Segment Dashboard; Definition and Scope, by Type
TABLE Global Healthcare CRO market, by Type 2015-2026 (USD Million)
TABLE Healthcare CRO market: Service Snapshot (2018)
TABLE Segment Dashboard; Definition and Scope, by Service
TABLE Global Healthcare CRO market, by Service 2015-2026 (USD Million)
TABLE Healthcare CRO market: Regional snapshot (2018)
TABLE Segment Dashboard; Definition and Scope, by Region
TABLE Global Healthcare CRO market, by Region 2015-2026 (USD Million)
TABLE North America Healthcare CRO market, by Country, 2015-2026 (USD Million)
TABLE North America Healthcare CRO market, by Type, 2015-2026 (USD Million)
TABLE North America Healthcare CRO market, by Service, 2015-2026 (USD Million)
TABLE Europe Healthcare CRO market, by Country, 2015-2026 (USD Million)
TABLE Europe Healthcare CRO market, by Type, 2015-2026 (USD Million)
TABLE Europe Healthcare CRO market, by Service, 2015-2026 (USD Million)
TABLE Asia Pacific Healthcare CRO market, by Country, 2015-2026 (USD Million)
TABLE Asia Pacific Healthcare CRO market, by Type, 2015-2026 (USD Million)
TABLE Asia Pacific Healthcare CRO market, by Service, 2015-2026 (USD Million)
TABLE Latin America Healthcare CRO market, by Country, 2015-2026 (USD Million)
TABLE Latin America Healthcare CRO market, by Type, 2015-2026 (USD Million)
TABLE Latin America Healthcare CRO market, by Service, 2015-2026 (USD Million)
TABLE Middle East and Africa Healthcare CRO market, by Country, 2015-2026 (USD Million)
TABLE Middle East and Africa Healthcare CRO market, by Type, 2015-2026 (USD Million)
TABLE Middle East and Africa Healthcare CRO market, by Service, 2015-2026 (USD Million)
List of Figures
FIGURE Healthcare CRO market segmentation
FIGURE Market research methodology
FIGURE Value chain analysis
FIGURE Porter’s Five Forces Analysis
FIGURE Market Attractiveness Analysis
FIGURE Competitive Landscape; Key company market share analysis, 2018
FIGURE Type segment market share analysis, 2019 & 2026
FIGURE Type segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Drug Discovery market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Target Validation market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Lead Identification market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Lead Optimization market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Clinical market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Phase I Trial Services market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Phase II Trial Services market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Phase III Trial Services market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Phase IV Trial Services market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Pre-Clinical market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Service segment market share analysis, 2019 & 2026
FIGURE Service segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Data Management market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Project Management/Clinical Supply Management market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Regulatory/Medical Affairs market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Clinical Monitoring market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Medical Writing market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Quality Management/Assurance market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Investigator Payments market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Biostatistics market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Laboratory market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Technology market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Site Recruitment market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Patient market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Others market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Regional segment market share analysis, 2019 & 2026
FIGURE Regional segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE North America Healthcare CRO market share and leading players, 2018
FIGURE Europe Healthcare CRO market share and leading players, 2018
FIGURE Asia Pacific Healthcare CRO market share and leading players, 2018
FIGURE Latin America Healthcare CRO market share and leading players, 2018
FIGURE Middle East and Africa Healthcare CRO market share and leading players, 2018
FIGURE North America market share analysis by Country, 2018
FIGURE U.S. Healthcare CRO market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Canada Healthcare CRO market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Europe Healthcare CRO market share analysis by Country, 2018
FIGURE Germany Healthcare CRO market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Spain Helthcare CRO market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Italy Healthcare CRO market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE UK Healthcare CRO market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE France Healthcare CRO market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Rest of the Europe Healthcare CRO market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Asia Pacific Healthcare CRO market share analysis by Country, 2018
FIGURE India Healthcare CRO market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE China Healthcare CRO market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Japan Healthcare CRO market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE South Korea Healthcare CRO market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Singapore Healthcare CRO market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Rest of APAC Healthcare CRO market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Latin America Healthcare CRO market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Latin America Healthcare CRO market share analysis by country, 2018
FIGURE Brazil Healthcare CRO market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Mexico Healthcare CRO market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Argentina Healthcare CRO market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Rest of LATAM Healthcare CRO market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Middle East and Africa Healthcare CRO market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Middle East and Africa Healthcare CRO market share analysis by Country, 2018
FIGURE Saudi Arabia Healthcare CRO market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE United Arab Emirates Healthcare CRO market size, forecast and trend analysis, 2015 to 2026 (USD Million)
